Compounds > glucagon
Page last updated: 2024-09-04

glucagon and Granulocytic Leukemia, Chronic

glucagon has been researched along with Granulocytic Leukemia, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alacacioglu, I; Bilgir, F; Bilgir, O; Binicier, O; Calan, M; Kebapcilar, L; Oner, P; Payzin, B; Sari, I1
Alacacioglu, I; Bilgir, F; Bilgir, O; Karaca, B; Kebapcilar, L; Oner, P; Sarì, I1

Other Studies

2 other study(ies) available for glucagon and Granulocytic Leukemia, Chronic

ArticleYear
Does imatinib mesylate therapy cause growth hormone deficiency?
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2009, Volume: 18, Issue:5

    Topics: Adult; Benzamides; Female; Glucagon; Human Growth Hormone; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Levodopa; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines

2009
Is there any relationship between imatinib mesylate medication and hypothalamic-pituitary-adrenal axis dysfunction?
    International journal of clinical practice, 2010, Volume: 64, Issue:1

    Topics: Adrenocorticotropic Hormone; Adult; Aged; Antineoplastic Agents; Benzamides; Cosyntropin; Endocrine System Diseases; Female; Glucagon; Glucocorticoids; Hormones; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pituitary-Adrenal System; Protein Kinase Inhibitors; Pyrimidines

2010